In vitro activity of grepafloxacin againstHaemophilus influenzae andMoraxella catarrhalis
- 1 April 1998
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 17 (4) , 293-295
- https://doi.org/10.1007/bf01699991
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Pharmacokinetics of Grepafloxacin after Oral Administration of Single and Repeat Doses in Healthy Young MalesClinical Pharmacokinetics, 1997
- Synthesis and biological properties of substituted 1,4-dihydro-5-methyl-4-oxo-3-quinolinecarboxylic acidsBioorganic & Medicinal Chemistry, 1995
- Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartmentsJournal of Antimicrobial Chemotherapy, 1995
- Activity of CP 99, 219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepaloxacin against penicillin-susceptible and -resistant pneumococciJournal of Antimicrobial Chemotherapy, 1995
- Evaluation of OPC-17116 against important pathogens that cause respiratory tract infectionsAntimicrobial Agents and Chemotherapy, 1994
- Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various national committee for clinical laboratory standards susceptibility test methodsDiagnostic Microbiology and Infectious Disease, 1994
- In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116Antimicrobial Agents and Chemotherapy, 1992